NCT02029625

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: NVP Healthcare · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.

Detailed description

rosuvastatin and ezetimibe(anti-dyslipidemia)

Conditions

• Dyslipidemia

Interventions

Type	Name	Description
DRUG	NVP-1205	rosuvastatin/ezetimibe fixed dose combination orally, once daily on Period 1 or Period 2
DRUG	rosuvastatin and ezetimibe	coadministration of rosuvastatin and ezetimibe orally, once daily on Period 1 or Period 2

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-03-01
• Completion: 2014-03-01
• First posted: 2014-01-08
• Last updated: 2016-03-25

Locations

1 site across 1 country: South Korea